ROI Case Study: How Ranbaxy achieved 8.5x returns through Accounts Payable Process Transformation
Learn how Ranbaxy SSC leveraged Newgen solutions for F&A Transformation
Ranbaxy Laboratories Limited, a leading multinational pharmaceutical company, manufactures a wide range of affordable and high quality generic medicines.
Ranbaxy’s had set up a Shared Service Center (SSC) aimed at reducing cost and improving processes by focusing on centralization, optimization and standardization of F&A operations.
Newgen offered an Accounts Payable (AP) solution built on its Business Process Management (BPM) and Enterprise Content Management (ECM) Platform, which was scalable and future ready.
Key Benefits Achieved by the Customer:
- USD 1.6 million in cost savings
- 30% reduction in cycle times
- 35% improvement in FTE productivity
- > 95% on time payments
- 21% reduction in cost per invoice